• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015 Product Image

Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

  • ID: 992968
  • June 2009
  • Region: Australia
  • 120 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Animas Corporation
  • ARKRAY, Inc.
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Novo Nordisk A/S
  • MORE

Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Australia diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Australia

Scope

- The report provides diabetes care devices information broken down into detailed categories and segments in Australia.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Animas Corporation
  • ARKRAY, Inc.
  • Eli Lilly and Company
  • LifeScan, Inc.
  • Novo Nordisk A/S
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Diabetic Care Devices
3.2 Glucose Monitoring Devices
3.2.1 Blood Glucose Meters
3.2.2 Blood Glucose Strips
3.3 Insulin Delivery
3.3.1 InsulinPens
3.3.2 Insulin Syringes
3.3.3 Insulin Pumps
3.3.4 Traditional Insulin Pump Accessories
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Registration and Conformity Assessment
5.2 Advertising
5.3 Labeling and Packaging
5.4 Post-market Surveillance
5.5 Registration Fee
6 Pricing and Reimbursement
7 Distribution Structure
8 Diabetes Care Devices In Australia
8.1 Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
8.2 Diabetes Care Devices, Australia, Overall Revenue ($ mn), 2000-2015
8.3 Diabetes Care Devices, Australia, Category Volume (Units), 2000-2015
8.4 Diabetes Care Devices, Australia, Company Share (2007-2008)
9 Glucose Monitoring In Australia
9.1 Glucose Monitoring Overall Revenue (2000-2015)
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
9.2 Glucose Monitoring Overall Volume (2000-2015)
9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
9.3 Glucose Monitoring Average Price (2000-2015)
9.4 Glucose Monitoring Distribution Share (2007-2008)
9.5 Glucose Monitoring, Australia, Company Share (2007-2008)
10 Insulin Delivery In Australia
10.1 Insulin Delivery Overall Revenue (2000-2015)
10.1.1 Insulin Pens Overall Revenue (2000-2015)
10.2 Insulin Delivery Overall Volume (2000-2015)
10.2.1 Insulin Pens Overall Volume (2000-2015)
10.3 Insulin Delivery Average Price (2000-2015)
10.4 Insulin Delivery Distribution Share (2007-2008)
10.5 Insulin Delivery, Australia, Company Share (2007-2008)
11 Overview of Key Companies in Australia Diabetes Care Devices Market
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 Company Overview
11.1.2 Value Chain Analysis
11.1.3 F. Hoffmann-La Roche Ltd Pipeline Products
11.2 LifeScan, Inc.
11.2.1 Company Overview
11.2.2 LifeScan, Inc. Pipeline Products
11.3 Bayer HealthCare AG
11.3.1 Company Overview
11.3.2 Value Chain Analysis
11.3.3 Bayer HealthCare AG Pipeline Products
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Value Chain Analysis
11.4.3 Abbott Laboratories Pipeline Products
11.5 Novo Nordisk A/S
11.5.1 Company Overview
11.5.2 Novo Nordisk A/S Pipeline Products
11.6 Sanofi-Aventis
11.6.1 Company Overview
11.7 ARKRAY, Inc.
11.7.1 Company Overview
11.7.2 ARKRAY, Inc. Pipeline Products
11.8 Terumo Corporation
11.8.1 Company Overview
11.8.2 Value Chain Analysis
11.9 Animas Corporation
11.9.1 Company Overview
11.10 Eli Lilly and Company
11.10.1 Company Overview
11.10.2 Value Chain Analysis
11.10.3 Eli Lilly and Company Pipeline Products
11.11 AiMedics Pty Ltd
11.11.1 Company Overview
11.11.2 AiMedics Pty Ltd Pipeline Products
11.12 National Diagnostics Products Pty. Limited
11.12.1 Company Overview
11.13 Medtronic, Inc.
11.13.1 Company Overview
11.13.2 Value Chain Analysis
11.13.3 Medtronic, Inc. Pipeline Products
11.14 Becton, Dickinson and Company
11.14.1 Company Overview
11.14.2 Value Chain Analysis
11.15 Smiths Medical
11.15.1 Company Overview
11.15.2 Value Chain Analysis
11.16 Apex Biotechnology Corp.
11.16.1 Company Overview
11.17 National Diagnostics Products Pty. Limited
11.17.1 Company Overview
12 Appendix
12.1 Global Markets Direct Research Methodology
12.2 Coverage
12.3 Secondary Research
12.4 Primary Research
12.5 Models
12.6 Forecasts
12.7 Expert Panel Validation
12.8 Currency Conversion
12.9 Contact Us
12.10 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Infrastructure in Australia, 2005 17
Table 2: Healthcare Personnel in Australia, 2005 18
Table 3: Hospital Wards by Specialty in Australia, 2003-2007 19
Table 4: Doctors by Specialty in Australia, 2003-2007 20
Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007 31
Table 6: Fee for Registered Device in Australia, 2007 33
Table 7: Fee for Device Clinical Trial in Australia, 2007 34
Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007 34
Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007 35
Table 10: Fee for Registration of Listed Devices in Australia, 2007 35
Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007 36
Table 12: Fee for Registration of Included Devices in Australia, 2007 36
Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007 36
Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007 37
Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007 37
Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007 37
Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007 38
Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007 38
Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007 38
Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007 39
Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007 39
Table 22: Diabetes Care Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 42
Table 23: Diabetes Care Devices, Australia, Overall Revenue ($ mn), 2000-2015 43
Table 24: Diabetes Care Devices, Australia, Overall Revenue ($ mn), 2000-2015 44
Table 25: Diabetes Care Devices, Australia, Overall Revenue ($ mn), Historic, 2000-2008 45
Table 26: Diabetes Care Devices, Australia, Overall Revenue ($ mn), Forecast, 2008-2015 46
Table 27: Diabetes Care Devices, Australia, Category Volume (Units), 2000-2015 47
Table 28: Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2000-2008 48
Table 29: Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2008-2015 49
Table 30: Diabetes Care Devices, Australia, Company Share by Revenue ($ mn), 2007-2008 50
Table 31: Glucose Monitoring, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008 51
Table 32: Glucose Monitoring, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015 52
Table 33: Blood Glucose Meters, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 53
Table 34: Blood Glucose Meters, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 54
Table 35: Glucose Monitoring, Australia, Volume (Units) by Segment, Historic, 2000-2008 55
Table 36: Glucose Monitoring, Australia, Volume (Units) by Segment, Forecast, 2008-2015 56
Table 37: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008 57
Table 38: Blood Glucose Meters, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015 57
Table 39: Glucose Monitoring, Australia, Average Price ($), Historic, 2000-2008 58
Table 40: Glucose Monitoring, Australia, Average Price ($), Forecast, 2008-2015 58
Table 41: Glucose Monitoring, Australia, Distribution Share by Revenue ($mn), 2007-2008 58
Table 42: Glucose Monitoring, Australia, Company Share by Revenue ($ mn), 2007-2008 59
Table 43: Insulin Delivery, Australia, Revenue ($ mn) by Segment, Historic, 2000-2008 60
Table 44: Insulin Delivery, Australia, Revenue ($ mn) by Segment, Forecast, 2008-2015 61
Table 45: Insulin Pens, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 62
Table 46: Insulin Pens, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 63
Table 47: Insulin Delivery, Australia, Volume (Units) by Segment, Historic, 2000-2008 64
Table 48: Insulin Delivery, Australia, Volume (Units) by Segment, Forecast, 2008-2015 64
Table 49: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Historic, 2000-2008 65
Table 50: Insulin Pens, Australia, Volume (Units) by Sub-Segment, Forecast, 2008-2015 66
Table 51: Insulin Delivery, Australia, Average Price ($), Historic, 2000-2008 67
Table 52: Insulin Delivery, Australia, Average Price ($), Forecast, 2008-2015 67
Table 53: Insulin Delivery, Australia, Distribution Share by Revenue ($mn), 2007-2008 68
Table 54: Insulin Delivery, Australia, Company Share by Revenue ($ mn), 2007-2008 69
Table 55: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 73
Table 56: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 73
Table 57: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 73
Table 58: LifeScan, Inc. Pipeline Products by Equipment Type 74
Table 59: LifeScan, Inc. Pipeline Products by Development Stage 74
Table 60: LifeScan, Inc. Pipeline Products by Therapy Area 74
Table 61: LifeScan, Inc. Pipeline Products by Clinical Trials 75
Table 62: LifeScan, Inc. Pipeline Products by News Summary 75
Table 63: Bayer HealthCare AG Pipeline Products by Equipment Type 79
Table 64: Bayer HealthCare AG Pipeline Products by Development Stage 79
Table 65: Bayer HealthCare AG Pipeline Products by Therapy Area 79
Table 66: Bayer HealthCare AG Pipeline Products by News Summary 79
Table 67: Abbott Laboratories Pipeline Products by Equipment Type 83
Table 68: Abbott Laboratories Pipeline Products by Development Stage 83
Table 69: Abbott Laboratories Pipeline Products by Therapy Area 83
Table 70: Abbott Laboratories Pipeline Products by Clinical Trials 84
Table 71: Abbott Laboratories Pipeline Products by News Summary 84
Table 72: Novo Nordisk A/S Pipeline Products by Equipment Type 85
Table 73: Novo Nordisk A/S Pipeline Products by Development Stage 85
Table 74: Novo Nordisk A/S Pipeline Products by Therapy Area 85
Table 75: Novo Nordisk A/S Pipeline Products by Clinical Trials 85
Table 76: ARKRAY, Inc. Pipeline Products by Equipment Type 87
Table 77: ARKRAY, Inc. Pipeline Products by Development Stage 87
Table 78: ARKRAY, Inc. Pipeline Products by Clinical Trials 88
Table 79: ARKRAY, Inc. Pipeline Products by News Summary 88
Table 80: Eli Lilly and Company Pipeline Products by Equipment Type 95
Table 81: Eli Lilly and Company Pipeline Products by Development Stage 95
Table 82: Eli Lilly and Company Pipeline Products by Therapy Area 95
Table 83: Eli Lilly and Company Pipeline Products by Clinical Trials 95
Table 84: Eli Lilly and Company Pipeline Products by News Summary 95
Table 85: AiMedics Pty Ltd Pipeline Products by Equipment Type 96
Table 86: AiMedics Pty Ltd Pipeline Products by Development Stage 96
Table 87: AiMedics Pty Ltd Pipeline Products by Therapy Area 96
Table 88: AiMedics Pty Ltd Pipeline Products by Clinical Trials 97
Table 89: AiMedics Pty Ltd Pipeline Products by News Summary 97
Table 90: Medtronic, Inc. Pipeline Products by Equipment Type 101
Table 91: Medtronic, Inc. Pipeline Products By Development Stage 103
Table 92: Medtronic, Inc. Pipeline Products By Therapy Area 105
Table 93: Medtronic, Inc. Pipeline Products By Clinical Trials 107
Table 94: Medtronic, Inc. Pipeline Products By News Summary 108
Table 95: USD to Local Currency, Average Exchange Rate 2008 119

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Bayer HealthCare AG
Abbott Laboratories
Novo Nordisk A/S
Sanofi-Aventis
ARKRAY, Inc.
Terumo Corporation
Animas Corporation
Eli Lilly and Company
AiMedics Pty Ltd
National Diagnostics Products Pty. Limited
Medtronic, Inc.
Becton, Dickinson and Company
Smiths Medical
Apex Biotechnology Corp.
National Diagnostics Products Pty. Limited

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos